NES
SNOA icon

New England Securities’s Sonoma Pharmaceuticals SNOA Stock Holding History

New England Securities’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Hold
0
– – – 1576
2014
Q3 		– Hold
0
– – – 1610
2014
Q2 		– Sell
-1
Closed -$2.96K – 1662
2014
Q1 		$3K Buy
+1
New +$3.4K ﹤0.01% 1433

Other funds holding SNOA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

New England Securities's SNOA Position: Q4 2014 in Review

New England Securities held its Sonoma Pharmaceuticals (SNOA) position steady in Q4 2014 at 0 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.

New England Securities first reported a position in SNOA in Q1 2014 and has held it in 1 quarter since. The position peaked at $3K in Q1 2014. 15 funds tracked by Wall St. Rank hold SNOA as of Q4 2014.

  • New England Securities held 0 shares of Sonoma Pharmaceuticals worth $1K as of Q4 2014.
  • New England Securities left its Sonoma Pharmaceuticals share count unchanged in Q4 2014.
  • Sonoma Pharmaceuticals made up ﹤0.01% of New England Securities's portfolio in Q4 2014, its #1576 holding.
  • New England Securities first reported a position in Sonoma Pharmaceuticals in Q1 2014 and has held it in 1 quarter since.
  • New England Securities's Sonoma Pharmaceuticals position peaked at $3K in Q1 2014.
  • 15 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2014.

Based on New England Securities's 13F filing for Q4 2014, filed 26 Jan 2015.